Current Clinical Trials
Welcome To Clinical Trials of America
Clinical Trials of America is dedicated to advancing the medical profession while maintaining a strong dedication to the purpose, values and principles of good medical practice. Through scientific investigations into the effectiveness and safety of new medicines or medical devices, Clinical Trials of America helps patients find new hope for treatment and facilitates seamless physician participation.
A physician-founded and operated company, Clinical Trials of America is a full-service clinical trials company that delivers complete multi-specialty, multi-site services for Phase II-IV clinical trials. Clinical Trials of America has the systems, expertise and experience that enable doctors to provide convenient patient care and conduct clinical trials at their practices.
Clinical Trials of America continues to add to its established network of highly qualified physicians who act as principal investigators in clinical studies. Our network currently includes the following specialties: endocrinology, family practice, gastroenterology, gynecology neurology, obstetrics, ophthalmology, perinatology, psychiatry, radiology, urgent care and urology.
For general inquiries, or to participate in a clinical trial, inquire about clinical trail management or to schedule a consultation, please call us at (541) 349-0523. For more information, contact us.
CTOFA Recent News
News Releases – FOR IMMEDIATE RELEASE – October 2011 Clinical Trials of America Launches Crohn’s Study: Clinical Trials of America has launched a Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease Previously Treated with TNF Antagonist Therapy
Press Release – FOR IMMEDIATE RELEASE, February 2011 Clinical Trials of America has been awarded a study to evaluate the general effect of of a novel study drug in obesity treatment. The study will measure the effect of the study drug on body weight in non-diabetic obese subjects or overweight subjects with comorbidities. The study [...]